Helius Medical Technologies is trading 5.5% higher at $1.77 in a technical bounce following a significant decline in the previous session.

  • The stock is recovering from an 8.7% drop yesterday amid ongoing market volatility.
  • There are no new company-specific filings, analyst actions, or FDA updates to account for the move on July 9, 2026.
  • The gain aligns with a modest rise in broader U.S. indices, suggesting the move is driven by market sentiment rather than fundamental news.